StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) stock

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.51+0.08 (+17.64%)

Close on Nov 18, 2026Market cap $17.07MP/E –Yield –

Pasithea Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2022 it was 76.7%, against -14.7% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 202276.7%+91.4
FY2021Dec 31, 2021-14.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2022Sep 30, 202260.4%–
Q2 FY2022Jun 30, 2022-11.2%–
Q1 FY2022Mar 31, 20225.3%–

More Pasithea Therapeutics figures

See a number that looks wrong?